ACS Medicinal Chemistry Letters
Letter
kinetochore-associated kinase essential for the vertebrate mitotic
checkpoint. Cell 2001, 106, 83−93.
(6) Mills, G. B.; Schmandt, R.; McGill, M.; Amendola, A.; Hill, M.;
Jacobs, K.; May, C.; Rodricks, A. M.; Campbell, S.; Hogg, D. Expression
of TTK, a novel human protein kinase, is associated with cell
proliferation. J. Biol. Chem. 1992, 267, 16000−16006.
(19) Wengner, A. M.; Siemeister, G.; Koppitz, M.; Schulze, V.;
Kosemund, D.; Klar, U.; Stoeckigt, D.; Neuhaus, R.; Lienau, P.; Bader,
B.; Prechtl, S.; Doehr, O.; Raschke, M.; von Ahsen, O.; Elbi, C.; Bruns, I.;
Michels, M.; Kreft, B.; von Nussbaum, F.; Brands, M.; Mumberg, D.;
Ziegelbauer, K. Novel Mps1 kinase inhibitors with potent anti-tumor
activity. AACR 106th Annual Meeting, Philadelphia, PA April 1−5,
2015; #3090.
(20) Kusakabe, K.-I.; Yoshida, H.; Nozu, K.; Hashizume, H.; Tadano,
G.; Sato, J.; Tamura, Y.; Mitsuoka, Y. Fused imidazole derivative having
TTK inhibitory action. PCT. Int. Appl. WO2011013729, 2011.
(21) Klar, U.; Koppitz, M.; Jautelat, R.; Kosemund, D.; Bohlmann, R.;
Lienau, P.; Siemeister, G.; Wengner, A. M. Substituted Imidazopyr-
idazines PCT. Int. Appl. WO2012032031, 2012.
(7) Yuan, B.; Xu, Y.; Woo, J.-H.; Wang, Y.; Bae, Y. K.; Yoon, D.-S.;
Wersto, R. P.; Tully, E.; Wilsbach, K.; Gabrielson, E. Increased ex-
pression of mitotic checkpoint genes in breast cancer cells with
chromosomal instability. Clin. Cancer Res. 2006, 12, 405−410.
(8) Daniel, J.; Coulter, J.; Woo, J. H.; Wilsbach, K.; Gabrielson, E. High
levels of the Mps1 checkpoint protein are protective of aneuploidy in
breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 5384−5389.
(9) Kilpinen, S.; Ojala, K.; Kallioniemi, O. Analysis of kinase gene
expression patterns across 5681 human tissue samples reveals functional
genomic taxonomy of the kinome. PLoS One 2010, 5, e15068.
(10) Landi, M. T.; Dracheva, T.; Rotunno, M.; Figueroa, J. D.; Liu, H.;
Dasgupta, A.; Mann, F. E.; Fukuoka, J.; Hames, M.; Bergen, A. W.;
Murphy, S. E.; Yang, P.; Pesatori, A. C.; Consonni, D.; Bertazzi, P. A.;
Wacholder, S.; Shih, J. H.; Caporaso, N. E.; Jen, J. Gene expression
signature of cigarette smoking and its role in lung adenocarcinoma
development and survival. PLoS One 2008, 3, e1651.
(11) Daniel, J.; Coulter, J.; Woo, J. H.; Wilsbach, K.; Gabrielson, E.
High levels of the Mps1 checkpoint protein are protective of aneuploidy
in breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 5384−
5389.
(12) Santaguida, S.; Tighe, A.; D’Alise, A. M.; Taylor, S. S.; Musacchio,
A. Dissecting the role of MPS1 in chromosome biorientation and the
spindle checkpoint through the small molecule inhibitor reversine. J. Cell
Biol. 2010, 190, 73−87.
̀
(22) Jemaa, M.; Galluzzi, L.; Kepp, O.; Senovilla, L.; Brands, M.;
Boemer, U.; Koppitz, M.; Lienau, P.; Prechtl, S.; Schulze, V.; Siemeister,
G.; Wengner, A. M.; Mumberg, D.; Ziegelbauer, K.; Abrieu, A.; Castedo,
M.; Vitale, I.; Kroemer, G. Characterization of novel MPS1 inhibitors
with preclinical anticancer activity. Cell Death Differ. 2013, 20, 1532−
1545.
(23) Liu, Y.; Pauls, H. W.; Laufer, R.; Li, S.-W.; Sampson, P. B.; Feher,
M.; Ng, G.; Patel, Lang, Y. Pyrazolopyrimidine compounds. PCT. Int.
Appl. WO2014075168, 2014.
(24) Kusakabe, K.; Ide, N.; Daigo, Y.; Itoh, T.; Yamamoto, T.;
Hashizume, H.; Nozu, K.; Yoshida, H.; Tadano, G.; Tagashira, S.;
Higashino, K.; Okano, Y.; Sato, Y.; Inoue, M.; Iguchi, M.; Kanazawa, T.;
Ishioka, Y.; Dohi, K.; Kido, Y.; Sakamoto, S.; Ando, S.; Maeda, M.;
Higaki, M.; Baba, Y.; Nakamura, Y. Discovery of Imidazo[1,2-
b]pyridazine Derivatives: Selective and Orally Available Mps1 (TTK)
Kinase Inhibitors Exhibiting Remarkable Antiproliferative Activity. J.
Med. Chem. 2015, 58, 1760−1775.
(25) ACD/Structure Designer, version 12.01; Advanced Chemistry
Development, Inc.: Toronto, ON, Canada, 2012.
(26) Mason, J. M. Campbell Family Institute for Breast Cancer
Research; University Health Network, personal communication.
(13) Kwiatkowski, N.; Jelluma, N.; Filippakopoulos, P.; Soundararajan,
M.; Manak, M. S.; Kwon, M.; Choi, H. G.; Sim, T.; Deveraux, Q. L.;
Rottmann, S.; Pellman, D.; Shah, J. V.; Kops, G. J.; Knapp, S.; Gray, N. S.
Small-molecule kinase inhibitors provide insight into Mps1 cell cycle
function. Nat. Chem. Biol. 2010, 6, 359−368.
(14) Caldarelli, M.; Angiolini, M.; Disingrini, T.; Donati, D.; Guanci,
M.; Nuvoloni, S.; Posteri, H.; Quartieri, F.; Silvagni, M.; Colombo, R.
Synthesis and SAR of new pyrazolo[4,3-h]quinazoline-3-carboxamide
derivatives as potent and selective MPS1 kinase inhibitors. Bioorg. Med.
Chem. Lett. 2011, 21, 4507−4511.
(15) Naud, S.; Westwood, I. M.; Faisal, A.; Sheldrake, P.; Bavetsias, V.;
Atrash, B.; Cheung, K.-M. J.; Liu, M.; Hayes, A.; Schmitt, J.; Wood, A.;
Choi, V.; Boxall, K.; Mak, G.; Gurden, M.; Valenti, M.; de Haven
Brandon, A.; Henley, A.; Baker, R.; McAndrew, C.; Matijssen, B.; Burke,
R.; Hoelder, S.; Eccles, S. A.; Raynaud, F. I.; Linardopoulos, S.; van
Montfort, R. L.; Blagg, J. Structure-based design of orally bioavailable
1H-pyrrolo[3,2-c]pyridine inhibitors of mitotic kinase monopolar
spindle 1 (Mps1). J. Med. Chem. 2013, 56, 10045−10065.
(16) Colombo, R.; Caldarelli, M.; Mennecozzi, M.; Giorgini, M. L.;
Sola, F.; Cappella, P.; Perrera, C.; Re Depaolini, S.; Rusconi, L.; Cucchi,
U.; Avanzi, N.; Bertrand, J. A.; Bossi, R. T.; Pesenti, E.; Galvani, A.;
Isacchi, A.; Colotta, F.; Donati, D.; Moll, J. Targeting the mitotic
checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1
kinase. Cancer Res. 2010, 70, 10255−10264.
(17) Tardif, K. D.; Rogers, A.; Cassiano, J.; Roth, B. L.; Cimbora, D. M.;
McKinnon, R.; Peterson, A.; Douce, T. B.; Robinson, R.; Dorweiler, I.;
Davis, T.; Hess, M. A.; Ostanin, K.; Papac, D. I.; Baichwal, V.;
McAlexander, I.; Willardsen, J. A.; Saunders, M.; Christophe, H.; Kumar,
V. D.; Wettstein, D. A.; Carlson, R. O.; Williams, B. L. Characterization
of the cellular and antitumor effects of MPI-0479605, a small-molecule
inhibitor of the mitotic kinase (Mps1). Mol. Cancer Ther. 2011, 10,
2267−2275.
(18) Colombo, R.; Burbridge, M.; Rodriguez, M.; Cantero, F.;
Caldarelli, M.; Giorgini, M. L.; Sola, F.; Ballinari, D.; Ciomei, M.;
Bosotti, R.; Montagnoli, A.; Isacchi, A.; Donati, D.; Galvani, A.
Preclinical characterization of the novel TTK kinase inhibitor S81694
for the treatment of triple-negative breast cancer. AACR 106th Annual
Meeting, Philadelphia, PA, April 1−5, 2015; #1638.
E
ACS Med. Chem. Lett. XXXX, XXX, XXX−XXX